loadpatents
name:-0.014009952545166
name:-0.0083119869232178
name:-0.0067050457000732
Tester; Richland Wayne Patent Filings

Tester; Richland Wayne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tester; Richland Wayne.The latest application filed is for "salts of an epidermal growth factor receptor kinase inhibitor".

Company Profile
8.21.22
  • Tester; Richland Wayne - Marlborough MA
  • Tester; Richland Wayne - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 11,351,168 - Singh , et al. June 7, 2
2022-06-07
Salts of an epidermal growth factor receptor kinase inhibitor
Grant 11,292,772 - Lai , et al. April 5, 2
2022-04-05
Salts Of An Epidermal Growth Factor Receptor Kinase Inhibitor
App 20210017137 - Lai; Mei ;   et al.
2021-01-21
Substituted 2,4-diaminopyrimidines as kinase inhibitors
Grant 10,828,300 - Singh , et al. November 10, 2
2020-11-10
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 10,596,172 - Singh , et al.
2020-03-24
Salts of an epidermal growth factor receptor kinase inhibitor
Grant 10,570,099 - Lai , et al. Feb
2020-02-25
Heteroaryl Compounds And Uses Thereof
App 20190192512 - Singh; Juswinder ;   et al.
2019-06-27
Salts Of An Epidermal Growth Factor Receptor Kinase Inhibitor
App 20190152925 - Lai; Mei ;   et al.
2019-05-23
Heteroaryl Compounds And Uses Thereof
App 20190117650 - Singh; Juswinder ;   et al.
2019-04-25
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 10,010,548 - Singh , et al. July 3, 2
2018-07-03
Salts of an epidermal growth factor receptor kinase inhibitor
Grant 10,005,738 - Lai , et al. June 26, 2
2018-06-26
Substituted 2,4-diaminopyrimidines as kinase inhibitors
Grant 9,987,276 - Singh , et al. June 5, 2
2018-06-05
Salts Of An Epidermal Growth Factor Receptor Kinase Inhibitor
App 20170217904 - Lai; Mei ;   et al.
2017-08-03
Heteroaryl Compounds And Uses Thereof
App 20170100397 - Singh; Juswinder ;   et al.
2017-04-13
Heteroaryl Compounds And Uses Thereof
App 20170095475 - Tester; Richland Wayne ;   et al.
2017-04-06
Besylate salt of a BTK inhibitor
Grant 9,604,936 - Witowski , et al. March 28, 2
2017-03-28
Salts of an epidermal growth factor receptor kinase inhibitor
Grant 9,540,335 - Lai , et al. January 10, 2
2017-01-10
Heteroaryl Compounds And Uses Thereof
App 20160311780 - Singh; Juswinder ;   et al.
2016-10-27
Heteroaryl Compounds And Uses Thereof
App 20160303121 - Singh; Juswinder ;   et al.
2016-10-20
2,4-disubstituted pyrimidines as kinase inhibitors
Grant 9,409,921 - Singh , et al. August 9, 2
2016-08-09
Substituted 2,4-diaminopyrimidines as kinase inhibitors
Grant 9,296,737 - Singh , et al. March 29, 2
2016-03-29
Heteroaryl Compounds And Uses Thereof
App 20160030426 - Tester; Richland Wayne ;   et al.
2016-02-04
Substituted 2,4-diaminopyrimidines as kinase inhibitors
Grant 9,212,181 - Singh , et al. December 15, 2
2015-12-15
Salts Of An Epidermal Growth Factor Receptor Kinase Inhibitor
App 20150344441 - Lai; Mei ;   et al.
2015-12-03
Salts of an epidermal growth factor receptor kinase inhibitor
Grant 9,108,927 - Lai , et al. August 18, 2
2015-08-18
Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder
App 20150216865 - Westlin, III; William Frederick ;   et al.
2015-08-06
Heteroaryl Compounds And Uses Thereof
App 20140213574 - Singh; Juswinder ;   et al.
2014-07-31
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 8,710,222 - Singh , et al. April 29, 2
2014-04-29
Besylate Salt Of A Btk Inhibitor
App 20140057929 - Witowski; Steven Richard ;   et al.
2014-02-27
2,4-diaminopyrimidines useful as kinase inhibitors
Grant 8,609,679 - Singh , et al. December 17, 2
2013-12-17
Besylate salt of a BTK inhibitor
Grant 8,563,568 - Witowski , et al. October 22, 2
2013-10-22
Salts Of An Epidermal Growth Factor Receptor Kinase Inhibitor
App 20130267531 - Lai; Mei ;   et al.
2013-10-10
Heteroaryl Compounds And Uses Thereof
App 20130165462 - Singh; Juswinder ;   et al.
2013-06-27
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 8,450,335 - Singh , et al. May 28, 2
2013-05-28
Heteroaryl Compounds And Uses Thereof
App 20130072469 - Singh; Juswinder ;   et al.
2013-03-21
Heteroaryl Compounds And Uses Thereof
App 20130065879 - Singh; Juswinder ;   et al.
2013-03-14
Heteroaryl Compounds And Uses Thereof
App 20130065899 - Singh; Juswinder ;   et al.
2013-03-14
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 8,338,439 - Singh , et al. December 25, 2
2012-12-25
Besylate Salt Of A Btk Inhibitor
App 20120077832 - Witowski; Steven Richard ;   et al.
2012-03-29
Heteroaryl Compounds And Uses Thereof
App 20100249092 - Singh; Juswinder ;   et al.
2010-09-30
Heteroaryl Compounds and Uses Thereof
App 20100029610 - Singh; Juswinder ;   et al.
2010-02-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed